Standard: Human gastric cancer organoids

Area of Science:

• Biomedical research
• Cancer biology
• Translational medicine

Background:

• Gastric cancer is a prevalent malignancy with a poor prognosis.
• Patient-derived gastric cancer organoids are emerging as valuable in vitro models.
• These organoids closely mimic patient characteristics, aiding research.

Discussion:

• A new guideline, "Human Gastric Cancer Organoid," has been released in China.
• It standardizes terminology, technical requirements, and assessment protocols.
• This aims to ensure consistent production, evaluation, and quality control.

Key Insights:

• Patient-derived gastric cancer organoids provide realistic in vitro models.
• Standardization is crucial for reliable research and clinical translation.
• The guideline facilitates best practices and international collaboration.

Outlook:

• Advancing the international standardization of human gastric cancer organoids.
• Facilitating clinical development and therapeutic applications.
• Improving outcomes for gastric cancer patients through enhanced research models.